Phenytoin Antibody (Mouse Monoclonal)

Description

Mouse Phenytoin Antibody (Monoclonal). 6 different clones are available.

References

• Phenytoin: 80 years young, from epilepsy to breast cancer, a remarkable molecule with multiple modes of action. Keppel Hesselink JM, Kopsky DJ. J Neurol. 2017 Aug;264(8):1617-1621.
• Fosphenytoin and phenytoin in patients with status epilepticus: improved tolerability versus increased costs. DeToledo JC, Ramsay RE. Drug Saf. 2000 Jun;22(6):459-66.
• Application of in vivo metabolomics to preclinical/toxicological studies: case study on phenytoin-induced systemic toxicity. Kamp H, Fabian E, Groeters S, Herold M, Krennrich G, Looser R, Mattes W, Mellert W, Prokoudine A, Ruiz-Noppinger P, Strauss V, Walk T, Wiemer J, van Ravenzwaay B. Bioanalysis. 2012 Sep;4(18):2291-301.
• Unbound phenytoin plasma concentrations in patients comedicated with sodium valproate–the predictive value of plasma albumin concentration. Johnson GJ, Kilpatrick CJ, Bury RW, Fullinfaw RO, Moulds RF. Br J Clin Pharmacol. 1989 Jun;27(6):843-9.
• Phenytoin prodrug 3-phosphoryloxymethyl phenytoin (ACC-9653): pharmacokinetics in patients following intravenous and intramuscular administration. Boucher BA, Bombassaro AM, Rasmussen SN, Watridge CB, Achari R, Turlapaty P. J Pharm Sci. 1989 Nov;78(11):929-32.
• Pharmacokinetics of phenytoin following intravenous and intramuscular administration of fosphenytoin and phenytoin sodium in the rabbit. Muchohi SN, Kokwaro GO, Maitho TE, Munenge RW, Watkins WM, Edwards G. Eur J Drug Metab Pharmacokinet. 2002 Apr-Jun;27(2):83-9.
• Phenytoin pharmacokinetics following oral administration of phenytoin suspension and fosphenytoin solution to rats. Burstein AH, Cox DS, Mistry B, Eddington ND. Epilepsy Res. 1999 Apr;34(2-3):129-33.
• Phenytoin as an effective treatment for polymorphic ventricular tachycardia due to QT prolongation in a patient with multiple drug intolerances. Yager N, Wang K, Keshwani N, Torosoff M. BMJ Case Rep. 2015 Jun 12;2015:bcr2015209521.